List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #40,371 to #40,420.
- PPD skin test → Mantoux test
- PPD test → Mantoux test
- PPE → Palmar plantar erythrodysesthesia
- PPGSS → Papular purpuric gloves and socks syndrome
- PPH → Pulmonary hypertension
- PPI → Proton pump inhibitor
- PPM → Artificial pacemaker
- PPM infection → Nonvalvular cardiovascular device-related infections
- PPP → Primary Prevention Project
- PPT → Postpartum thyroiditis
- PPV → Positive predictive value
- PPoma → Neuroendocrine tumors
- PQRST → Probucol Quantitative Regression Swedish Trial
- PRACTICAL → Comparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction
- PRAGUE → Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
- PRAGUE-8 → Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
- PRAISE → Prospective Randomized Amlopidine Survival Evaluation
- PRAISE-1 → Prospective Randomized Amlodipine Survival Evaluation-1
- PRAISE-2 → Prospective Randomized Amlodipine Survival Evaluation-2
- PREAMI → Perindopril Remodeling In Elderly With Acute Myocardial Infarction
- PRECISE → Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
- PREDICT → Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
- PREMIAR → Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
- PREMIER → Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
- PREPAIR → Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
- PREPARE — Presented at TCT 2008 → Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
- PREPIC → A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
- PRESENT → Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
- PRESERVE → Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
- PRESTO → Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
- PREVEND IT → Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
- PREVENT(Radiation) → Proliferation Reduction With Vascular Energy Trial
- PREVENT (Dalteparin) → Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
- PREVENT (Warfarin) → Venous thromboembolism
- PREVENT II → The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
- PREVENT IV → Project Of Ex-Vivo Vein Graft Engineering Via Transfection
- PRF1 → Perforin
- PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
- PRIMA — Presented at ACC.09/i2 → Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
- PRIME-2 → Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
- PRIMI → Pro-Urokinase For Myocardial Infarction
- PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
- PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
- PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
- PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
- PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
- PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
- PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
- PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
- PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions